Gene targeting studies provide compelling evidence that glycolysis in spermatozoa rather than mitochondrial ATP production is essential for maintaining sperm motility and male fertility in the mouse. Although human sperm exhibit high glycolytic activity, there are conflicting reports on the relative importance of glycolysis and mitochondrial oxidative phosphorylation for maintaining ATP levels in these cells. In addition, there are a surprising number of glycolytic variants in mammalian sperm, and recent studies continue to uncover new enzymes and regulatory features of both glycolytic and other metabolic enzymes.
Specific aims of this proposal will: i) Determine if energy production in mouse sperm is regulated by novel mechanisms. We will a) determine if substrates other than glucose sustain sperm motility and functional properties sufficient for in vitro fertilization, b) use metabolomic and fluxomic approaches to determine how sperm metabolize effective substrates, and c) determine if PKA-mediated phosphorylation in sperm is essential for maintaining glycolytic ATP production. 2) Identify substrates that maintain ATP production and motility in human sperm and determine how they are metabolized. To test the hypothesis that human sperm require glycolysis for fertilization competence, we will a) determine if both glycolysable and non-glycolysable substrates are required to maintain sperm function, b) use metabolomic approaches to assess how effective substrates are metabolized by human sperm, and c) determine if there is evidence for glycolytic defects in infertile men with low sperm motility. 3) Determine functional characteristics of newly identified glycolytic isozymes that are present in sperm. These studies will test the hypothesis that extensive modifications of sperm glycolysis sperm are essential for alternative regulatory mechanisms and/or binding of pathway constituents to the fibrous sheath to provide a localized supply of ATP along the length of the flagellum. We will a) determine the diversity of LDH isozymes present in mouse sperm, b) determine if aldolase A and novel LDH isozymes present in mouse and human sperm have unique functional properties, and c) use genomic analyses to assess the complexity of isoforms that are used at other steps of the sperm glycolytic pathway. Knowledge gained from these studies will increase our understanding of how glycolysis is regulated in sperm and provide insights regarding the relative utility of specific sperm isozymes as potential contraceptive targets.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD035041-15
Application #
8248598
Study Section
Special Emphasis Panel (ZHD1)
Project Start
2011-04-01
Project End
2014-03-31
Budget Start
2011-04-01
Budget End
2013-03-31
Support Year
15
Fiscal Year
2011
Total Cost
$247,884
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Danshina, Polina V; Qu, Weidong; Temple, Brenda R et al. (2016) Structural analyses to identify selective inhibitors of glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme. Mol Hum Reprod 22:410-26
Franasiak, Jason M; Holoch, Kristin J; Yuan, Lingwen et al. (2014) Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ???3 testing in women with unexplained infertility. Fertil Steril 101:1724-31
Su, Shifeng; Minges, John T; Grossman, Gail et al. (2013) Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins. J Biol Chem 288:24809-24
Lenhart, Patricia M; Broselid, Stefan; Barrick, Cordelia J et al. (2013) G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol 51:191-202
Minges, John T; Su, Shifeng; Grossman, Gail et al. (2013) Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers. J Biol Chem 288:1939-52
Askew, Emily B; Minges, John T; Hnat, Andrew T et al. (2012) Structural features discriminate androgen receptor N/C terminal and coactivator interactions. Mol Cell Endocrinol 348:403-10
Plante, Beth J; Lessey, Bruce A; Taylor, Robert N et al. (2012) G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod Sci 19:684-93
Su, Shifeng; Blackwelder, Amanda J; Grossman, Gail et al. (2012) Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation. J Biol Chem 287:34809-24
Goodson, Summer G; Qiu, Yunping; Sutton, Keith A et al. (2012) Metabolic substrates exhibit differential effects on functional parameters of mouse sperm capacitation. Biol Reprod 87:75
Lagarde, William H; Blackwelder, Amanda J; Minges, John T et al. (2012) Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation. J Biol Chem 287:10905-15

Showing the most recent 10 out of 147 publications